315 related articles for article (PubMed ID: 29286008)
21. Plasmid profiles among some ESKAPE pathogens in a tertiary care centre in south India.
Ragupathi NKD; Bakthavatchalam YD; Mathur P; Pragasam AK; Walia K; Ohri VC; Veeraraghavan B
Indian J Med Res; 2019 Feb; 149(2):222-231. PubMed ID: 31219087
[TBL] [Abstract][Full Text] [Related]
22. Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital.
Hwang H; Kim B
Sci Rep; 2018 Oct; 8(1):14757. PubMed ID: 30283084
[TBL] [Abstract][Full Text] [Related]
23. Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011.
Haeili M; Ghodousi A; Nomanpour B; Omrani M; Feizabadi MM
J Infect Dev Ctries; 2013 Apr; 7(4):312-7. PubMed ID: 23592640
[TBL] [Abstract][Full Text] [Related]
24. Association Between Healthcare-Associated Infection and Exposure to Hospital Roommates and Previous Bed Occupants with the Same Organism.
Cohen B; Liu J; Cohen AR; Larson E
Infect Control Hosp Epidemiol; 2018 May; 39(5):541-546. PubMed ID: 29486805
[TBL] [Abstract][Full Text] [Related]
25. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
Hamouche E; Sarkis DK
Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
[TBL] [Abstract][Full Text] [Related]
26. Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017.
Ismail H; Lowman W; Govind CN; Swe Swe-Han K; Maloba MRB; Bamford C; Perovic O
S Afr Med J; 2019 Nov; 109(12):934-940. PubMed ID: 31865955
[TBL] [Abstract][Full Text] [Related]
27. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.
Kunz AN; Brook I
Chemotherapy; 2010; 56(6):492-500. PubMed ID: 21099222
[TBL] [Abstract][Full Text] [Related]
28. Eliciting antibiotics active against the ESKAPE pathogens in a collection of actinomycetes isolated from mountain soils.
Zhu H; Swierstra J; Wu C; Girard G; Choi YH; van Wamel W; Sandiford SK; van Wezel GP
Microbiology (Reading); 2014 Aug; 160(Pt 8):1714-1725. PubMed ID: 24794971
[TBL] [Abstract][Full Text] [Related]
29. Detection of ESKAPE Bacterial Pathogens at the Point of Care Using Isothermal DNA-Based Assays in a Portable Degas-Actuated Microfluidic Diagnostic Assay Platform.
Renner LD; Zan J; Hu LI; Martinez M; Resto PJ; Siegel AC; Torres C; Hall SB; Slezak TR; Nguyen TH; Weibel DB
Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27986722
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. study.
Seifert H; Blondeau J; Dowzicky MJ
Int J Antimicrob Agents; 2018 Oct; 52(4):474-484. PubMed ID: 30012439
[TBL] [Abstract][Full Text] [Related]
31. In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens.
Younis W; AbdelKhalek A; Mayhoub AS; Seleem MN
Curr Pharm Des; 2017; 23(14):2147-2157. PubMed ID: 28190396
[TBL] [Abstract][Full Text] [Related]
32. Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli.
De Socio GV; Rubbioni P; Botta D; Cenci E; Belati A; Paggi R; Pasticci MB; Mencacci A
J Glob Antimicrob Resist; 2019 Dec; 19():154-160. PubMed ID: 31112804
[TBL] [Abstract][Full Text] [Related]
33. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.
Potron A; Poirel L; Nordmann P
Int J Antimicrob Agents; 2015 Jun; 45(6):568-85. PubMed ID: 25857949
[TBL] [Abstract][Full Text] [Related]
34. Patients transferred from Libya to Denmark carried OXA-48-producing Klebsiella pneumoniae, NDM-1-producing Acinetobacter baumannii and meticillin-resistant Staphylococcus aureus.
Hammerum AM; Larsen AR; Hansen F; Justesen US; Friis-Møller A; Lemming LE; Fuursted K; Littauer P; Schønning K; Gahrn-Hansen B; Ellermann-Eriksen S; Kristensen B
Int J Antimicrob Agents; 2012 Aug; 40(2):191-2. PubMed ID: 22743013
[No Abstract] [Full Text] [Related]
35. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
36. Etiological factors causing lower respiratory tract infections isolated from hospitalized patients.
Guzek A; Rybicki Z; Korzeniewski K; Mackiewicz K; Saks E; Chciałowski A; Zwolińska E
Adv Exp Med Biol; 2015; 835():37-44. PubMed ID: 25310945
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii.
Garza-González E; Llaca-Díaz JM; Bosques-Padilla FJ; González GM
Chemotherapy; 2010; 56(4):275-9. PubMed ID: 20693798
[TBL] [Abstract][Full Text] [Related]
38. Bacteremia due to ESKAPE pathogens: An emerging problem in cancer patients.
El-Mahallawy HA; Hassan SS; El-Wakil M; Moneer MM
J Egypt Natl Canc Inst; 2016 Sep; 28(3):157-62. PubMed ID: 27268592
[TBL] [Abstract][Full Text] [Related]
39. [Surveillance of antimicrobial resistance: VIRA study 2004].
Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; Gómez M;
Enferm Infecc Microbiol Clin; 2004 Nov; 22(9):517-25. PubMed ID: 15511392
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility pattern of tracheal tube isolates from Intensive Care Unit of Fauji Foundation Hospital Rawalpindi.
Shah AA; Jamil B; Naseem S; Khan AW; Ali Y; Hussain K; Abbasi SA
J Pak Med Assoc; 2019 Jul; 69(7):981-984. PubMed ID: 31308567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
